Your session is about to expire
← Back to Search
Achieving My Potential: A Randomized, Controlled Trial of a Telephone-Based Developmental Care Coordination System (AMP Trial)
N/A
Waitlist Available
Led By Paul J Chung, MD MS
Research Sponsored by University of California, Los Angeles
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be younger than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 months after enrollment
Awards & highlights
No Placebo-Only Group
Summary
This trial tests if a phone service can help parents of young children get better access to developmental evaluations and services. It focuses on young children and aims to see if this approach leads to more children getting the help they need.
Eligible Conditions
- Health Services Research
- Child Development
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 6 months after enrollment
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 months after enrollment
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Child Developmental Outcomes
Intervention Cost / Benefit Analysis
Referral to, eligibility for, and receipt of early childhood developmental services 6 months after enrollment
Secondary study objectives
Number of referrals, number of children eligible for services, and number of children who have received services
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Intervention + Usual Care + Developmental Screening ResultsExperimental Treatment1 Intervention
Intervention group families will receive usual care and developmental screening results will be shared with each child's primary care provider. In addition, they will be connected via telephone to 2-1-1 prior to their scheduled well-child visit for the telephone-based early childhood development care coordination intervention.
Group II: Usual Care + Developmental Screening ResultsActive Control1 Intervention
This group will receive usual care. In addition, developmental screening results will be shared with each child's primary care provider.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Telephone-based early childhood developmental care coordination
2020
N/A
~570
Find a Location
Who is running the clinical trial?
University of California, Los AngelesLead Sponsor
1,569 Previous Clinical Trials
10,313,724 Total Patients Enrolled
Kaiser Permanente School of MedicineOTHER
1 Previous Clinical Trials
102 Total Patients Enrolled
Virginia Commonwealth UniversityOTHER
719 Previous Clinical Trials
22,895,271 Total Patients Enrolled
Information and Referral Federation of Los Angeles County (211 LA County)UNKNOWN
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)NIH
2,068 Previous Clinical Trials
2,747,142 Total Patients Enrolled
Paul J Chung, MD MSPrincipal InvestigatorKaiser Permanente School of Medicine
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- The child has been diagnosed with a developmental or behavioral disorder, or has received services for such a disorder.You cannot participate in the study if your parent does not speak English or Spanish.
Research Study Groups:
This trial has the following groups:- Group 1: Usual Care + Developmental Screening Results
- Group 2: Intervention + Usual Care + Developmental Screening Results
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.